CRL-2265 CEM/C1 人急性**细胞白血病细胞

]资料

点击看大图

如果您对该产品感兴趣的话,可以

产品名称: CRL-2265 CEM/C1 人急性**细胞白血病细胞
产品型号: CRL-2265
产品厂商: 美国标准生物品收藏中心（ATCC）
产品文档: 无相关文档

简单介绍

CRL-2265 CEM/C1 人急性**细胞白血病细胞， ATCC 细胞|细胞系|细胞株|肿瘤细胞|细胞；细胞库管理规范，提供的细胞株背景清楚，提供参考文献和培养条件！

CRL-2265 CEM/C1 人急性**细胞白血病细胞的详细介绍

CRL-2265 CEM/C1 人急性**细胞白血病细胞

ATCC^® Number:

CRL-2265™

Price:

Designations:	CEM/C1
Depositors:	WG Harker
Biosafety Level:	1
Shipped:	frozen
Medium & Serum:	See Propagation
Growth Properties:	suspension
Organism:	Homo sapiens
Morphology:	lymphoblast
Source:	Organ: peripheral blood Disease: acute lymphoblastic leukemia Cell Type: T lymphoblast;
Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age:	4 years
Gender:	female
Ethnicity:	Caucasian
Comments:	CEM/C1 is a camptothecin (CPT) resistant derivative of the human T cell leukemia cell line CCRF-CEM (see ATCC CCL-119). The cell line was selected and subcloned in 1991 for resistance to CPT. The cells exhibit cross resistance to both the water soluble (topotecan) and water insoluble (9-amino-CPT and 10,11-methylenedioxy-CPT) analogs of CPT. CEM/C1 cells are approximately 31 fold less sensitive to CPT than the parental CEM cells. CEM/C1 cells display atypical multidrug resistance (MDR) and altered topoisomerase I catalytic activity. Resistance to CPT is stable for up to six months.
Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Temperature: 37.0°C
Subculturing:	Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of medium. Establish new cultures at 2 X 10 exp5 viable cells/ml and maintain between 1 X 10 exp5 and 2 X 10 exp6.
Preservation:	culture medium 95%; DMSO, 5%
Doubling Time:	26 hrs
Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001 recommended serum:ATCC 30-2020 parental cell line:ATCC CCL-119
References:	22339: Kapoor R, et al. Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin. Oncol. Res. 7: 83-95, 1995. PubMed: 7579731 23117: Fujimori A, et al. Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin. Cancer Res. 55: 1339-1346, 1995. PubMed: 7882333

产品留言

标题

联系人

联系电话

内容

验证码

点击换一张

注：1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!

细胞系，ATCC细胞，ATCC菌种，细胞系目录，ATCC，鼠伤寒沙门氏菌，atcc细胞库，人**瘤细胞，人食管癌细胞，ATCC 19404，ATCC 25922，ATCC 19146，微生物菌种，细胞株，标准菌株，ATCC中国，atcc上海代理，CMCC 菌株，ATCC菌株，细胞目录，质控菌株，肿瘤细胞株，乳腺癌细胞系，人肝癌细胞系

产品目录